Hypermethylation of p15 gene associated with an inferior poor long-term outcome in childhood acute lymphoblastic leukemia

Journal of Cancer Research and Clinical Oncology

Volumn 142, Issue 2, 2016, Pages 497-504

  Mai, Huirong ^a,b   Liu, Xiaolan ^b   Chen, Yixin ^c   Li, Changgang ^b   Cao, Lizhi ^d   Chen, Xiaowen ^b   Chen, Senmin ^b   Liu, Guosheng ^a   Wen, Feiqiu ^a,b  

^a THE FIRST AFFILIATED HOSPITAL OF JINAN UNIVERSITY   (China)

^b SHENZHEN CHILDREN'S HOSPITAL   (China)

^c SHENZHEN PEOPLE'S HOSPITAL   (China)

^d CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Acute lymphoblastic leukemia; Children; Event free survival; Methylation; p15 gene

Indexed keywords

CDKN2B PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 2B; DNA;

ACUTE LYMPHOBLASTIC LEUKEMIA; CASE CONTROL STUDY; CHILD; CPG ISLAND; DNA METHYLATION; FEMALE; GENETICS; HL 60 CELL LINE; HUMAN; MALE; METABOLISM; PRESCHOOL CHILD; PROGNOSIS; PROMOTER REGION; THROMBOCYTOPENIA;

CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CPG ISLANDS; CYCLIN-DEPENDENT KINASE INHIBITOR P15; DNA METHYLATION; DNA, NEOPLASM; FEMALE; HL-60 CELLS; HUMANS; MALE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; PROMOTER REGIONS, GENETIC; THROMBOCYTOPENIA;

EID: 84955746360     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-015-2063-6     Document Type: Article

References (37)

1. Agrawal S, Unterberg M, Koschmieder S et al (2007) DNA methylation of tumor suppressor genes in clinical remission predicts the relapse risk in acute myeloid leukemia. Cancer Res 67:1370–1377
2. Bird A (2002) DNA methylation patterns and epigenetic memery. Genes Dev 16:6–21
3. Boiltwood J, Wainscoat JS (2007) Gene silencing by DNA methylation in haematological malignancies. Br J Haematol 138:3–11
4. Bruggenmann M, van der Velden VH, Raff T et al (2004) Rearranged T-cell receptor beta genes represent powerful targets for quantification of minimal residual disease in childhood and adult T-cell acute lymphoblastic leukemia. Leukemia 18:709–719
5. Cameron EE, Baylin SB et al (1999) p15INK4B CpG island methylation in primary acute leukemia is heterogeneous and suggests density as a critical factor for transcriptional silencing. Blood 94:2445–2451
6. Chim CS, Wong AS, Kwong YL et al (2003) Epigenetic inactivation of INK4/CDK/RB cell cycle pathway in acute leukemias. Ann Hematol 82:738–742
7. Das PM, Singal R (2004) DNA methylation and cancer. J Clin Oncol 22:4632–4642
8. Esteller M (2003) Profiling aberrant methylation in hematologic neoplasms: a view from the tip of the iceberg. Clin Immunol 109:80–88
9. Esteller M, Corn PG, Baylin SB, Herman JG (2001) A gene hypermethylation profile of human cancer. Cancer Res 61:3225–3229
10. Garcia-Manero G, Jeha S, Daniel J et al (2003) Aberrant DNA methylation in pediatric patients with acute lymphoblastic leukemia. Cancer 97:695–702
11. Gardiner RB, Morash BA, Riddell C et al (2012) Using MS-MLPA as an efficient screening tool for detecting 9p21 abnormalities in pediatric acute lymphoblastic leukemia. Pediatric Blood Cancer 58(6):852–859
12. Gokbuget N, Kneba M, Raff T et al (2002) Risk-adapted treatment according to minimal residual disease in adult ALL. Best Pract Res Clin Haematol 15:639–652
13. Gutierrez MI, Siraj AK, Bhargava M, Ozbek U, Banavali S, Chaudhary MA, Solh HEI, Bhatia K (2003) Concurrent methylation of multiple genes in childhood ALL: correlation with phenotype and molecular subgroup. Leukemia 17:1845–1850
14. Herman JG, Baylin SB (2003) Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 349:2042–2054
15. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB (1996a) Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93:9821–9826
16. Herman JG, Jen J, Merlo A, Baylin SB (1996b) Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4BI. Cancer Res 56:722–727
17. Inokuchi K, Iwakiri R, Futaki M et al (1998) Minimal residual disease in acute myelogenous leukemia with PML/RARα or AML/ETO mRNA and phenotypic analysis of possible T and natural killer cells in bone marrow. Leuk Lymphoma 29:553–561
18. Iravani M, Dhat R, Price CM (1997) Methylation of the multi tumor suppressor gene-2 (MTS2, CDKN1, p15INK4B) in childhood acute lymphoblastic leukemia. Oncogene 15:2609–2614
19. Kalebic T (2003) Epigenetic changes: potential therapeutic targets. Ann NY Acad Sci 983:278–285
20. Khaldon B, Yazan H, Asem A et al (2014) DNA hypermethylation of cell cycle (p15 and p16) and apoptotic (p14, p53, DAPK and TMS1) genes in peripheral blood of leukemia patients. Asian Pac J Cancer Prev 15:75–84
21. Kim M, Yim SH, Cho NS et al (2009) Homozygous deletion of CDKN2A (p16, p14) and CDKN2B (p15) genes is a poor prognostic factor in adult but not in childhood B-lineage acute lymphoblastic leukemia: a comparative deletion and hypermethylation study. Cancer Genet Cytogenet 195:59–65
22. Locatelli F, Moretta F, Rutella S (2013) Management of relapsed acute lymphoblastic leukemia in childhood with conventional and innovative approaches. Curr Opin Oncol 25:707–715
23. Pane F, Cimino G, Izzo B et al (2005) Significant reduction of the hybrid BCR/ABL transcripts after induction and consolidation therapy is a powerful predictor of treatment response in adult Philadelphia-positive acute lymphoblastic leukemia. Leukemia 19:628–635
24. Preisler HD, Li B, Chen H et al (2001) p15INK4B gene methylation and expression in normal, myelodysplastic, and acute myelogenous leukemia cells and in the marrow cells of cured lymphoma patients. Leukemia 15:1589–1595
25. Pui CH (2010) Recent research advances in childhood acute lymphoblastic leukemia. J Formos Med Assoc 109:777–787
26. Roman-Gomez J, Jimenez-Velasco A, Castillejo JA et al (2004) Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemia. Blood 104:2492–2498
27. Roman-Gomez J, Jimenez-Velasco A, Agirre X et al (2006) CpG island methylator phenotype redefines the prognostic effect of t(12;21) in childhood acute lymphoblastic leukemia. Clin Cancer Res 12:4845–4850
28. Sherr CJ, Roberts JM (1999) CDK inhibitors: positive and negative regulators of GI-phase progression. Genes Dev 13:1501–1512
29. Singal R, Ginder GD (1999) DNA methylation. Blood 93:4059–4070
30. Stary J, Zimmermann M, Campbell M et al (2014) Intensive chemotherapy for childhood acute lymphoblastic leukemia: results of the randomized intercontinental trial ALL IC-BFM 2002. Clin Oncol 32:174–184
31. Suzuki MM, Bird A (2008) DNA methylation landscapes: provocative insights from epigenomics. Nat Rev Genet 9:465–476
32. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (eds) (2008) WHO classification of tumors of haematopoietic and lymphoid tissue. IARC, Lyon
33. Takeuchi S, Matsushita M, Zimmermann M et al (2011) Clinical significance of aberrant DNA methylation in childhood acute lymphoblastic leukemia. Leuk Res 35:1345–1349
34. Tsellou E, Troungos C, Moschovi M, Athanasiadou-Piperopoulou F, Polychronopoulou S, Kosmidis H, Kalmanti M, Hatzakis A, Dessypris N, Kalofoutis A, Petridou E (2005) Hypermethylation of CpG islands in the promoter region of the p15INK4B gene in childhood acute leukaemia. Eur J Cancer 41:584–589
35. Xiong Z, Laird PW (1997) COBRA: a sensitive and quantitative DNA methylation assay. Nucleic Acids Res 25:2532–2534
36. Yu W, Gius D, Onyango P, Muldoon-Jacobs K, Karp J, Feinberf AP, Cui H (2008) Epigenetic silencing of tumor suppressor gene p15 by its antisense RNA. Nature 451:20–206
37. Zheng S, Ma X, Zhang L, Gunn L, Smith MT, Wiemels JL, Leung K, Buffler PA, Wiencke JK (2004) Hypermethylation of the 5′ CpG island of the FHIT gene is associated with hyperdiploid and translocation-negative subtypes of pediatric leukemia. Cancer Res 64:2000–2006